Late last month, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI) was signed into law.[1] The Act is a much anticipated reauthorization of the Pandemic and All-Hazards Preparedness Act, originally passed in 2006.[2] The legislation is a key development in strengthening the country’s ability to respond to bio-threats, disasters, and other national emergencies by defining federal program initiatives and funding states and private researchers. PAHPAI-authorized grants allow for the research and development of biodefense measures and the stockpiling of preparedness supplies.
More Posts
New DOJ Cooperation Credit Guidelines a Welcome Sign, but Key Questions Remain Unresolved
A Tale of Two Protests: Recent GAO Decisions Highlight Impaired Objectivity OCIs
Signs of Progress with the Limitations on Subcontracting, but Outstanding Questions Remain
DoD OIG Audit: What SDVOSBs Need to Know
Subscribe: Subscribe via RSS